HCA Healthcare Inc. (HCA)
HCA Healthcare Statistics
Share Statistics
HCA Healthcare has 246.2M shares outstanding. The number of shares has increased by -4.24% in one year.
Shares Outstanding | 246.2M |
Shares Change (YoY) | -4.24% |
Shares Change (QoQ) | -1.85% |
Owned by Institutions (%) | 60.45% |
Shares Floating | 174.51M |
Failed to Deliver (FTD) Shares | 669 |
FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 4.4M, so 1.74% of the outstanding shares have been sold short.
Short Interest | 4.4M |
Short % of Shares Out | 1.74% |
Short % of Float | 2.43% |
Short Ratio (days to cover) | 3.36 |
Valuation Ratios
The PE ratio is 13.48 and the forward PE ratio is 11.78. HCA Healthcare's PEG ratio is 0.86.
PE Ratio | 13.48 |
Forward PE | 11.78 |
PS Ratio | 1.1 |
Forward PS | 0.9 |
PB Ratio | -31.02 |
P/FCF Ratio | 13.76 |
PEG Ratio | 0.86 |
Enterprise Valuation
HCA Healthcare Inc. has an Enterprise Value (EV) of 114.66B.
EV / Earnings | 19.91 |
EV / Sales | 1.62 |
EV / EBITDA | 8.27 |
EV / EBIT | 29.06 |
EV / FCF | 20.33 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of -18.08.
Current Ratio | 1.08 |
Quick Ratio | 0.97 |
Debt / Equity | -18.08 |
Total Debt / Capitalization | 105.85 |
Cash Flow / Debt | 0.23 |
Interest Coverage | 1.91 |
Financial Efficiency
Return on equity (ROE) is -2.3% and return on capital (ROIC) is 6.73%.
Return on Equity (ROE) | -2.3% |
Return on Assets (ROA) | 0.1% |
Return on Capital (ROIC) | 6.73% |
Revenue Per Employee | $312,402.65 |
Profits Per Employee | $25,486.73 |
Employee Count | 226,000 |
Asset Turnover | 1.19 |
Inventory Turnover | n/a |
Taxes
Income Tax | 1.87B |
Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by 2.59% in the last 52 weeks. The beta is 1.69, so HCA Healthcare's price volatility has been higher than the market average.
Beta | 1.69 |
52-Week Price Change | 2.59% |
50-Day Moving Average | 324.36 |
200-Day Moving Average | 345.73 |
Relative Strength Index (RSI) | 61.68 |
Average Volume (20 Days) | 1.65M |
Income Statement
In the last 12 months, HCA Healthcare had revenue of 70.6B and earned 5.76B in profits. Earnings per share was 22.27.
Revenue | 70.6B |
Gross Profit | 70.6B |
Operating Income | 3.95B |
Net Income | 5.76B |
EBITDA | 13.86B |
EBIT | 3.95B |
Earnings Per Share (EPS) | 22.27 |
Balance Sheet
The company has 1.93B in cash and 45.24B in debt, giving a net cash position of -43.3B.
Cash & Cash Equivalents | 1.93B |
Total Debt | 45.24B |
Net Cash | -43.3B |
Retained Earnings | -2.12B |
Total Assets | 59.51B |
Working Capital | 1.24B |
Cash Flow
In the last 12 months, operating cash flow was 10.51B and capital expenditures -4.88B, giving a free cash flow of 5.64B.
Operating Cash Flow | 10.51B |
Capital Expenditures | -4.88B |
Free Cash Flow | 5.64B |
FCF Per Share | 21.81 |
Margins
Gross margin is 100%, with operating and profit margins of 5.59% and 8.16%.
Gross Margin | 100% |
Operating Margin | 5.59% |
Pretax Margin | 12.07% |
Profit Margin | 8.16% |
EBITDA Margin | 19.63% |
EBIT Margin | 5.59% |
FCF Margin | 7.99% |
Dividends & Yields
HCA pays an annual dividend of $2.7, which amounts to a dividend yield of 0.82%.
Dividend Per Share | $2.70 |
Dividend Yield | 0.82% |
Dividend Growth (YoY) | 9.09% |
Payout Ratio | 12.27% |
Earnings Yield | 6.51% |
FCF Yield | 6.69% |
Analyst Forecast
The average price target for HCA is $384, which is 12.2% higher than the current price. The consensus rating is "Buy".
Price Target | $384 |
Price Target Difference | 12.2% |
Analyst Consensus | Buy |
Analyst Count | 15 |
Scores
Altman Z-Score | 2.6 |
Piotroski F-Score | 6 |